GlaxoSmithKline (GSK), Innoviva (INVA) Announce Filing of FF/UMEC/VI Submission with FDA for Use in COPD
Tweet Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (Nasdaq: INVA) announced the filing by GSK of a regulatory submission with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
